Progressive Ataxia, Focal Seizures, and Malabsorption Syndrome in a 41 Year Old Woman
JNNP 60:225-230, Mumford,C.J.,et al, 1996
A Man with Weight Loss, Ataxia, and Confusion for 3 Months
Lancet 347:448, Beversdorf,D.,et al, 1996
Does Cryptic Gluten Sensitivity Play a Part in Neurological Illness?
Lancet 347:369-370, Hadjivassiliou,M.,et al, 1996
Proving the Worth of Neurologists?
Neurol 46:276-277, Hillen,M.E.&Sage,J.I., 1996
Cyclosporine-Associated Mutism in Liver Transplant Patients
Neurol 46:252-254, Valldeoriola,F.,et al, 1996
Neurotoxicity Related to the Use of Topical Tretinoin (Retin-A)
Ann Int Med 124:227-228, Bernstein,A.L.&Leventhal-Rochon,J.L., 1996
Chronic Lymphocytic Leukemia and the Central Nervous System:A clinical and Pathological Study
Neurol 46:19-25, Cramer,S.C.,et al, 1996
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
NEJM 334:71-76, Bennett,D.A.,et al, 1996
Prognostic Value of the Hyperdense Middle Cerebral Artery Sign and Stroke Scale Score Before Ultraearly Thrombolytic Therapy
AJNR 17:79-85, Tomsick,T.,et al, 1996
Acute Spinal Injury
NEJM 334:514-520, Chiles,B.W.&Cooper,P.R., 1996
The Syndrome of Posterior Choroidal Artery Territory Infarction
Ann Neurol 39:779-788, Neau,J.&Bogousslavsky,J., 1996
Natural History of Progressive Supranuclear Palsy & Clin Predictors of Survival:A Clinicopath Study
JNNP 61:615-620, Litvan,I.,et al, 1996
Conduction Aphasia in Multiple Sclerosis:A Case Report with MRI Findings
Neurol 47:576-578, Arnett,P.A.,et al, 1996
Delayed-Onset Cerebellar Syndrome
Arch Neurol 53:450-454, Louis,E.D.,et al, 1996
Dementia After First Stroke
Stroke 27:1205-1210, Censori,B.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
The Ambulatory Workload of Office-Based Neurologists
Arch Neurol 53:379-381, Menken,M., 1996
Assessment of Plasmapheresis
Report of the Therapeutics and Technology Assessment Subcommittee of the AAN, Neurol 47:840-8431996., , 1996
Cost-Effectiveness Analysis:What Is It and How Will It Influence Neurology
Ann Neurol 39:818-823, Holloway,R.G., 1996
The"Gulf War Syndrome"-Is There Evidence of Dysfunction in the Nervous System
JNNP 60:449-451, Jamal,G.A.,et al, 1996
The World-Wide Burden of Neurologic Disease
Neurol 47:21-25, Bergen,D.C., 1996
BSE Linked to New Variant of CJD in Humans
BMJ 312:795, 791, 843, 85496., , 1996
A New Variant of Creutzfeldt-Jakob Disease in the UK
Lancet 347:921-925, 915, 916, 91796., Will,R.G.,et al, 1996
Seven-Year Follow-up of Neurologic Involvement in Behcet Syndrome
Arch Neurol 53:691-694, Akman-Demir,G.,et al, 1996
MR Findings in Listerial Rhombencephalitis
AJNR 17:593-596, Alper,G.,et al, 1996
Neurologic Consequences of HTLV-II Infection in Injection-Drug Users
Neurol 46:1556-1560, Dooneief,G.,et al, 1996
Wolfram Syndrome:Hereditary Diabetes Mellitus with Brainstem and Optic Atrophy
Ann Neurol 39:352-360, Scolding,N.J.,et al, 1996
Leigh Syndrome:Clinical Features and Biochemical DNA Abnormalities
Ann Neurol 39:343-351, Rahman,S.,et al, 1996
Niemann-Pick Disease Type C from Bench to Bedside
JAMA 276:561-564, Schiffmann,R., 1996
Neurological Signs, Aging, and the Neurodegenerative Syndromes
Arch Neurol 53:498-502, Waite,L.M.,et al, 1996
Cerebral Infarction Associated with Kearns-Sayre Syndrome-Related Cardiomyopathy
Neurol 46:826-828, Provenzale,J.M.,et al, 1996
Leptomeningeal Carcinomatosis:Presenting Features and Prognostic Factors
Arch Neurol 53:626-632, Balm,M.&Hammack,J., 1996
Opsoclonus
Semin Neurol 16:21-26, Averbuch-Heller,L.&Remler,B., 1996
Diffuse Lewy Body Disease:Clinical Features in Nine Cases without Coexistent Alzheimer's Disease
JNNP 60:531-538, Hely,M.A.,et al, 1996
Transient Encephalopathy after Paclitaxel (Taxol) Infusion
Neurol 46:1596-1599, Perry,J.R.&Warner,E., 1996
Early CT Signs in Acute Middle Cerebral Artery Infarction:Predictive Value for Subsequent Infarct Locations and Outcome
Neurol 47:366-375, Moulin,T.,et al, 1996
Assessment:Electronystagmography, Report of the Therapeutics and Technology Assessment Subcommittee
Neurol 46:1763-1766, Ferguson,J.H.,et al, 1996
Acute Disseminated Encephalomyelitis:MR and CT Features
AJNR 17:104-109, Mader,I.,et al, 1996
Cortical Hyperintensity on Proton Density-Weighted Images:An MR Sign of Cyclosporine-Related Encephalopathy
AJNR 17:337-344, Jansen,O.,et al, 1996
Clinicopathological Study of 35 Cases of Multiple System Atrophy
JNNP 58:160-166, Wenning,G.K.,et al, 1995
Some Specific Clinical Features Differentiate Multiple System Atrophy (Striatonigral Variety) from Parkinson's Disease
Arch Neurol 52:294-298, Colosimo,C.,et al, 1995
Wernicke Encephalopathy with Symmetric Pericentral Involvement:MR Findings
J Comput Assist Tomogr 19:306-308, Yamashita,M.&Yamamoto,T., 1995
Clinical, Neuropath & Genetic Studies of Large Spinocerebellar Ataxia Type 1 (SCA1) Kindred: (CAG) n Early Premonitory Signs & Symp
Neurol 45:24-30, Genis,D.,et al, 1995
Autosomal Dominant Cerebellar Phenotypes:The Genotype has Settled the Issue
Neurol 45:1-5, Rosenberg,R.N., 1995
Charcot-Marie-Tooth Neuropathies:From Clinical Description to Molecular Genetics
Muscle & Nerve 18:267-275995., Ionasecu,V.V., 1995
Leukoencephalopathy with Swelling & A Discrepantly Mild Clinical Course in Eight Children
Ann Neurol 37:324-334, van der Knaap,M.S.,et al, 1995
A Novel Mutation in Exon 3 of the Proteolipid Protein Gene in Pelizaeus-Merzabacher Disease
Neurol 45:394-395, Pratt,V.M.,et al, 1995
Sarin Poisoning in Matsumoto, Japan
Lancet 346:290-293, Morita,H.,et al, 1995
Neuroblastoma-Associated Opsoclonus-Myoclonus Treated with IVIgG
J Pediatr 127:328-329, Petruzzi,M.J.&deAlarcon,P.A., 1995
Paraneoplastic Cerebellar Degeneeration with Anti-Yo Antibody in a Man
Neurol 45:1226-1227, Felician,O.,et al, 1995